Literature DB >> 9039985

Identification of a common low density lipoprotein receptor mutation (R329X) in the south of England: complete linkage disequilibrium with an allele of microsatellite D19S394.

I N Day1, L Haddad, S D O'Dell, L B Day, R A Whittall, S E Humphries.   

Abstract

Familial hypercholesterolaemia is commonly caused by mutations in the low density lipoprotein receptor (LDLR) gene and more than 300 different mutations have been described worldwide. Some mutations occur at relatively higher frequency in certain populations, reflecting both chance and demography, most evident in founder populations. As part of a study of kindreds of 78 probands from Southampton and south west Hampshire, we identified the same mutation (R329X) in 9/78 (11.5%) probands. In all (100%) of these probands, length allele 259nt of the 17 allele microsatellite D19S394, sited approximately 250 kilobases telomeric and 5' to the LDLR gene, was observed, although in the general population this allele has a prevalence of only 16.1%. A simple diagnostic assay for R329X was constructed in conjunction with more detailed family studies. Both the R329X and linked D19S394 allele also cosegregated with the FH phenotype within each kindred. Although R329X involves a CpG site, it is highly likely that the families are identical by descent for R329X, we surmise with a common ancestor within 500 to 1000 years, although the mutation is not restricted to this geographical area. This relationship illustrates that the linkage disequilibrium of gene LDLR with marker D19S394 will enable rapid recognition using D19S394 genotype of possible common FH mutation(s) within a cohort of FH patients from a particular locality or ethnic group.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039985      PMCID: PMC1050862          DOI: 10.1136/jmg.34.2.111

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  19 in total

1.  Common low-density lipoprotein receptor mutations in the French Canadian population.

Authors:  E Leitersdorf; E J Tobin; J Davignon; H H Hobbs
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

2.  An integrated metric physical map of human chromosome 19.

Authors:  L K Ashworth; M A Batzer; B Brandriff; E Branscomb; P de Jong; E Garcia; J A Garnes; L A Gordon; J E Lamerdin; G Lennon; H Mohrenweiser; A S Olsen; T Slezak; A V Carrano
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

3.  Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

Authors:  J P Kane; M J Malloy; T A Ports; N R Phillips; J C Diehl; R J Havel
Journal:  JAMA       Date:  1990-12-19       Impact factor: 56.272

4.  Combination treatment with cholestyramine and bezafibrate for heterozygous familial hypercholesterolaemia.

Authors:  L D Curtis; A C Dickson; K L Ling; J Betteridge
Journal:  BMJ       Date:  1988-07-16

5.  Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners.

Authors:  E Leitersdorf; D R Van der Westhuyzen; G A Coetzee; H H Hobbs
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

6.  Identification of the 664 proline to leucine mutation in the low density lipoprotein receptor in four unrelated patients with familial hypercholesterolaemia in the UK.

Authors:  L King-Underwood; V Gudnason; S Humphries; M Seed; D Patel; B Knight; A Soutar
Journal:  Clin Genet       Date:  1991-07       Impact factor: 4.438

7.  Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects.

Authors:  T P Leren; K Solberg; O K Rødningen; S Tonstad; L Ose
Journal:  Atherosclerosis       Date:  1994-12       Impact factor: 5.162

8.  Mutations in the low density lipoprotein receptor gene of familial hypercholesterolemic patients detected by denaturing gradient gel electrophoresis and direct sequencing.

Authors:  P Lombardi; E J Sijbrands; K van de Giessen; A H Smelt; J J Kastelein; R R Frants; L M Havekes
Journal:  J Lipid Res       Date:  1995-04       Impact factor: 5.922

9.  High-throughput method for determination of apolipoprotein E genotypes with use of restriction digestion analysis by microplate array diagonal gel electrophoresis.

Authors:  M K Bolla; L Haddad; S E Humphries; A F Winder; I N Day
Journal:  Clin Chem       Date:  1995-11       Impact factor: 8.327

10.  Identification of deletions in the human low density lipoprotein receptor gene.

Authors:  B Horsthemke; A Dunning; S Humphries
Journal:  J Med Genet       Date:  1987-03       Impact factor: 6.318

View more
  6 in total

1.  Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins.

Authors:  M A Austin; P J Talmud; L A Luong; L Haddad; I N Day; B Newman; K L Edwards; R M Krauss; S E Humphries
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

2.  Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.

Authors:  Steve E Humphries; Treena Cranston; Marcus Allen; Helen Middleton-Price; Maryam C Fernandez; Victoria Senior; Emma Hawe; Andrew Iversen; Richard Wray; Martin A Crook; Anthony S Wierzbicki
Journal:  J Mol Med (Berl)       Date:  2005-12-31       Impact factor: 4.599

3.  Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemia.

Authors:  D Norman; X M Sun; M Bourbon; B L Knight; R P Naoumova; A K Soutar
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

4.  LDLR Database (second edition): new additions to the database and the software, and results of the first molecular analysis.

Authors:  M Varret; J P Rabés; R Thiart; M J Kotze; H Baron; A Cenarro; O Descamps; M Ebhardt; J C Hondelijn; G M Kostner; Y Miyake; M Pocovi; H Schmidt; H Schuster; M Stuhrmann; T Yamamura; C Junien; C Béroud; C Boileau
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

5.  Identification of a common low density lipoprotein receptor mutation (C163Y) in the west of Scotland.

Authors:  W K Lee; L Haddad; M J Macleod; A M Dorrance; D J Wilson; D Gaffney; M H Dominiczak; C J Packard; I N Day; S E Humphries; A F Dominiczak
Journal:  J Med Genet       Date:  1998-07       Impact factor: 6.318

6.  Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic.

Authors:  Marta Futema; Ros A Whittall; Amy Kiley; Louisa K Steel; Jackie A Cooper; Ebele Badmus; Sarah E Leigh; Fredrik Karpe; H Andrew W Neil; Steve E Humphries
Journal:  Atherosclerosis       Date:  2013-04-18       Impact factor: 5.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.